Skip to main content
. 2020 Sep 24;12(10):2751. doi: 10.3390/cancers12102751

Figure 1.

Figure 1

PI3K/AKT/mTOR signalling pathway SMIs for the treatment of endometrial cancer. Current SMIs under clinical investigation and their target molecules are displayed. Abbreviations: RTK, Receptor Tyrosine Kinase.